Carl B Shanholtz, Michael L Terrin, Thelma Harrington, Caleb Chan, Whittney Warren, Robert Walter, Faith Armstrong, Jeffrey Marshall, Rachel Scheraga, Abjihit Duggal, Perry Formanek, Michael Baram, Majid Afshar, Nathaniel Marchetti, Sunit Singla, John Reilly, Dan Knox, Nitin Puri, Kevin Chung, Clayton H Brown, Jeffrey D Hasday
The Cooling to Help Injured Lungs (CHILL) trial is an open label, two group, parallel design multicenter, randomized phase IIB clinical trial assessing the efficacy and safety of targeted temperature management with combined external cooling and neuromuscular blockade to block shivering in patients with early moderate-severe acute respiratory distress syndrome (ARDS). This report provides the background and rationale for the clinical trial and outlines the methods using the Consolidated Standards of Reporting Trials guidelines...
June 2023: Contemporary Clinical Trials Communications